Observational Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Mar 21, 2015; 21(11): 3337-3343
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3337
Table 3 Sensitivity analysis of cost-effectiveness analysis and cost-utility analysis of different screening programs for Gallstone disease
VariableBase caseRangeThreshold of CEAThreshold of CUA
Annual screening
Screening cost (NTD)13821000-500004163040082
Indirect cost (NTD)2318340-635670Dominate1Dominate1
Percentage of cholecystectomy0.80.1-0.9Dominate1Dominate1
Biennial screening
Screening cost (NTD)13821000-500003877137250
Indirect cost (NTD)2318340-635670Dominate1Dominate1
Percentage of cholecystectomy0.80.1-0.9Dominate1Dominate1
3-yr screening
Screening cost (NTD)13821000-500003604836003
Indirect cost (NTD)2318340-635670Dominate1Dominate1
Percentage of cholecystectomy0.80.1-0.9Dominate1Dominate1
4-yr screening
Screening cost (NTD)13821000-500003218631952
Indirect cost (NTD)2318340-635670Dominate1Dominate1
Percentage of cholecystectomy0.80.1-0.9Dominate1Dominate1
5-yr screening
Screening cost (NTD)13821000-500002906328579
Indirect cost (NTD)2318340-635670Dominate1Dominate1
Percentage of cholecystectomy0.80.1-0.9Dominate1Dominate1